Low-dose IL-2 reduces IL-21+ T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients
View ORCID ProfileJia-Yuan Zhang, View ORCID ProfileFiona Hamey, Dominik Trzupek, View ORCID ProfileMarius Mickunas, View ORCID ProfileMercede Lee, View ORCID ProfileLeila Godfrey, View ORCID ProfileJennie H.M. Yang, View ORCID ProfileMarcin L Pekalski, View ORCID ProfileJane Kennet, Frank Waldron-Lynch, View ORCID ProfileMark Evans, View ORCID ProfileTimothy I. M. Tree, View ORCID ProfileLinda S. Wicker, View ORCID ProfileJohn A. Todd, View ORCID ProfileRicardo C. Ferreira
doi: https://doi.org/10.1101/2022.04.05.22273167
Jia-Yuan Zhang
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Fiona Hamey
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Dominik Trzupek
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Marius Mickunas
2Department of Immunobiology, King’s College London, School of Immunology and Microbial Sciences, London, United Kingdom
Mercede Lee
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Leila Godfrey
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Jennie H.M. Yang
2Department of Immunobiology, King’s College London, School of Immunology and Microbial Sciences, London, United Kingdom
Marcin L Pekalski
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Jane Kennet
3Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, University of Cambridge Addenbrooke’s Hospital, Cambridge, United Kingdom
Frank Waldron-Lynch
4Vertex Pharmaceuticals, Vertex Cell & Gene Therapies, Boston, Massachusetts, United States of America
Mark Evans
5National Institute for Health Research, Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom
Timothy I. M. Tree
2Department of Immunobiology, King’s College London, School of Immunology and Microbial Sciences, London, United Kingdom
Linda S. Wicker
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
John A. Todd
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Ricardo C. Ferreira
1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
Posted April 05, 2022.
Low-dose IL-2 reduces IL-21+ T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients
Jia-Yuan Zhang, Fiona Hamey, Dominik Trzupek, Marius Mickunas, Mercede Lee, Leila Godfrey, Jennie H.M. Yang, Marcin L Pekalski, Jane Kennet, Frank Waldron-Lynch, Mark Evans, Timothy I. M. Tree, Linda S. Wicker, John A. Todd, Ricardo C. Ferreira
medRxiv 2022.04.05.22273167; doi: https://doi.org/10.1101/2022.04.05.22273167
Low-dose IL-2 reduces IL-21+ T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients
Jia-Yuan Zhang, Fiona Hamey, Dominik Trzupek, Marius Mickunas, Mercede Lee, Leila Godfrey, Jennie H.M. Yang, Marcin L Pekalski, Jane Kennet, Frank Waldron-Lynch, Mark Evans, Timothy I. M. Tree, Linda S. Wicker, John A. Todd, Ricardo C. Ferreira
medRxiv 2022.04.05.22273167; doi: https://doi.org/10.1101/2022.04.05.22273167
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (195)
- Cardiovascular Medicine (2873)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12596)
- Forensic Medicine (10)
- Gastroenterology (809)
- Genetic and Genomic Medicine (4470)
- Geriatric Medicine (405)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1054)
- Hematology (378)
- HIV/AIDS (905)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4225)
- Nursing (226)
- Nutrition (619)
- Oncology (2215)
- Ophthalmology (628)
- Orthopedics (255)
- Otolaryngology (321)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1179)
- Primary Care Research (485)
- Public and Global Health (6810)
- Radiology and Imaging (1499)
- Respiratory Medicine (904)
- Rheumatology (430)
- Sports Medicine (371)
- Surgery (474)
- Toxicology (59)
- Transplantation (204)
- Urology (175)